Transitional cell ovarian carcinoma in a BRCA1 mutation carrier

Obstetrics and Gynecology

Volumn 99, Issue 5 SUPPL. 1, 2002, Pages 944-946

  Rao, Gautam G ^a   Ashfaq, Raheela ^a   Schorge, John O ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; ASCITES; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CASE REPORT; FAMILY HISTORY; FEMALE; FROZEN SECTION; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC SCREENING; GERM LINE; HUMAN; INTRAOPERATIVE PERIOD; LAPAROTOMY; MENOPAUSE; MUTATOR GENE; OMENTUM; ONCOGENE; OVARY CARCINOMA; PELVIS; PREMENOPAUSE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CLIMACTERIC; FEMALE; GENES, BRCA1; HETEROZYGOTE; HUMANS; MUTATION; OVARIAN NEOPLASMS;

EID: 0036227215     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)01936-1     Document Type: Article

References (8)

1. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
2. Risks of cancer in BRCA1-mutation carriers
3. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
4. Clinical and pathologic features of ovarian cancer in women with germ-line mutations of BRCA1
5. Ovarian carcinomas with transitional cell carcinoma pattern
6. BRCA1 5382 insC mutation in a sporadic and familial breast and ovarian carcinoma in Scotland
7. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families